← Petco Health & Wellness Company, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|
| Total cost of sales | $2.5b | $2.8b | $3.4b | $3.6b | $3.9b | $3.8b | $3.7b | |
| Gross profit | $1.9b | $2.1b | $2.4b | $2.4b | $2.4b | $2.3b | $2.3b | |
| Operating income (loss) | $110.6m | $194.4m | $266.1m | $225.6m | ($1.2b) | $7.1m | $120.4m | |
| Goodwill impairment | — | — | $0 | $0 | $1.2b | — | $0 | |
| Interest income | ($335k) | ($653k) | ($62k) | ($1.0m) | ($3.4m) | ($3.7m) | ($6.3m) | |
| Loss on partial extinguishment of debt | — | $17.5m | $20.8m | — | $920k | — | $565k | |
| Other non-operating income | — | — | ($34.5m) | $12.7m | ($4.7m) | ($4.8m) | $0 | |
| Loss before income taxes and income from equity method investees | ($142.1m) | ($41.6m) | $202.4m | $112.3m | ($1.3b) | ($128.0m) | ($5.0m) | |
| Income from equity method investees | ($2.4m) | ($6.5m) | ($10.9m) | ($13.0m) | ($16.2m) | ($18.7m) | ($20.4m) | |
| Net loss attributable to noncontrolling interest | ($8.1m) | ($5.3m) | ($4.6m) | ($891k) | $0 | $0 | — | |
| Total net sales | $4.4b | $4.9b | $5.8b | $6.0b | $6.3b | $6.1b | $6.0b | |
| Consolidated net income (loss) | ($104.0m) | ($31.7m) | $159.8m | $89.9m | ($1.3b) | ($101.8m) | $9.1m | |
| Net income (loss) attributable to Class A and B-1 common stockholders | ($95.9m) | ($26.5m) | $164.4m | $90.8m | ($1.3b) | ($101.8m) | $9.1m | |
| Basic | ($0.46) | ($125.70) | $0.62 | $0.34 | ($4.79) | ($0.37) | $0.03 | |
| Diluted | ($0.46) | ($125.70) | $0.62 | $0.34 | ($4.79) | ($0.37) | $0.03 | |
| Selling, general and administrative expenses | $1.8b | $1.9b | $2.2b | $2.2b | $2.3b | $2.3b | $2.2b | |
| Interest expense | $253.0m | $219.1m | $77.4m | $101.6m | $150.9m | $143.5m | $131.2m | |
| Income tax expense (benefit) | ($35.7m) | ($3.3m) | $53.5m | $35.3m | ($27.6m) | ($7.5m) | $6.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.